Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

Assembloid CRISPR screens reveal impact of disease genes in human

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

Frontiers Prenatal Cadmium Exposure Alters Proliferation in

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

Generating human artery and vein cells from pluripotent stem cells

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

Protocol for observing microtubules and microtubule ends in both

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

FGFR2 mutations promote endometrial cancer progression through

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

The Mitochondrial Enzyme 17βHSD10 Modulates Ischemic and Amyloid-β

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

Efficient CRISPR-Cas9-mediated mutagenesis in primary human B

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

RNA molecular recording with an engineered RNA deaminase

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

IJMS, Free Full-Text

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entry

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

Frontiers The mitochondrial Ca2+ channel MCU is critical for

Invitrogen LV-MAX Lentiviral Packaging Mix 1.5 mL:Cell Culture

PTBP1 enforces ATR-CHK1 signaling determining the potency of CDC7